An international confederation of biotech bodies announced the formation of the International Council of Biotechnology Associations (ICBA) today, with the  purpose of advocating for public policies that support the growth of the innovative biotechnology industry worldwide.

Jim Greenwood, BIO’s President and Chief Executive Officer, was elected ICBA Chairman, and Nathalie Moll, Secretary General of EuropaBio, was elected Vice Chair, each serving a two-year term. The Council will meet annually at the BIO International Convention.

With the biotech sector facing challenges and opportunities that cross borders, the formation of the ICBA is “an important step that allows us to better coordinate, organize and face these issues around the world together,” said Greenwood.

Moll added that the Council “will advocate for more efficient and effective governance, science-based regulatory systems and the right framework conditions for competitiveness and innovation to ensure faster and more equitable access to biotech products and processes for patients… around the world.”

ICBA Founding Members are as follows:

AfricaBio – Africa

ASSOBIOTEC – Italy

Association of Biotechnology Led Enterprises – India

AusBiotech – Australia

Belgian Biotech Association – Belgium

BIO Deutschland – Germany

BioIndustry Association – United Kingdom

BIOTECanada – Canada

Biotechnology Industry Organization – United States of America

EuropaBio – Europe

Foro Argentino de Biotecnologia – Argentina

German Association of Biotechnology Industries – Germany

HollandBIO – Netherlands

Hungarian Biotech Association – Hungary

Japan Bioindustry Association – Japan

Norwegian Bioindustry Association – Norway

PeruBiotech – Peru

Portugal’s Biotechnology Industry Organization – Portugal

Spanish Bioindustry Association – Spain

Swiss Biotech Association – Switzerland

 

Source: PharmExec